Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Kedudukan dalam Saham #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Harga Saham
$0.089
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$15.36M
Perubahan (1 hari)
50.59%
Perubahan (1 tahun)
111.85%
Negara
US
Perdagangan Inhibitor Therapeutics, Inc. (INTI)

Kategori

Sejarah pecahan saham untuk Inhibitor Therapeutics, Inc. (INTI)
Saham Inhibitor Therapeutics, Inc. (simbol: INTI) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 18, 2026.
Satu saham INTI yang dibeli sebelum Aug 18, 2026 kini bersamaan dengan 0 saham INTI.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE